Blog2024-01-19T15:38:31+00:00

Blog

From Blueberry Therapeutics

Fungal Infection – Not Just Toenails

Onychomycosis (fungal nail infection) and tinea pedis (athlete’s foot), are some of the most common forms of fungal infection in adults and are often the first things that spring to mind when thinking of fungal infection. However, many other forms of fungal infection exist, which affect all different parts of the body and can have serious health implications.  Fungal [...]

By |July 4th, 2019|Categories: Blog Articles|Comments Off on Fungal Infection – Not Just Toenails

The rise of resistant Candida auris – A global issue

Fungal ‘superbug’ drug-resistant Candida auris has been identified by the Centres for Disease Control and Prevention (CDC) as a ‘serious threat to global health’ following a startling increase in the number of infection cases that do not respond to treatment over recent years.   Candida is most notably associated with thrush, which although not life-threatening, affects at least 135 million individuals world-wide1. The infection can however be lethal to [...]

By |June 3rd, 2019|Categories: Blog Articles|Tags: , , , , , , |Comments Off on The rise of resistant Candida auris – A global issue

Fungal Disease – A Global Opportunity for Improved Health in Developing Countries

As the World Health Organization focuses on what universal health coverage means in 2019, we explore the global challenges and opportunities in the control of fungal infection. Although we often think of fungal infection in a cosmetic context, only affecting aging populations and often in relation to fungal nail [...]

By |May 10th, 2019|Categories: Blog Articles|Tags: , , , , , , |Comments Off on Fungal Disease – A Global Opportunity for Improved Health in Developing Countries

UK-Based Nanomedicine firm set plans to initiate a large phase II efficacy study in 2019

Fungal Nail Infection (Onychomycosis) is the most common nail disorder.1 Risk factors such as trauma, old age, diabetes, immunosuppression, tinea pedis, psoriasis, and family history are leading to an increased prevalence.2 Onychomycosis is characterised by nail thickening, splitting, roughening and discolouration. Although viewed as ‘less serious’ than other infectious diseases, onychomycosis [...]

By |April 18th, 2019|Categories: Blog Articles|Tags: , , |Comments Off on UK-Based Nanomedicine firm set plans to initiate a large phase II efficacy study in 2019

Recent Posts

Categories

T: 01625 238776    
E: info@blueberrytherapeutics.com

Blueberry Therapeutics Ltd Blueberry Therapeutics, Mereside, Alderley Park, Alderley Edge, Cheshire, SK10 4TG.

Go to Top